2021 Program
Scientific Agenda & Speakers
FRIDAY JUNE 11, 2021
09h00 Welcome & Opening Remarks Peter Dicpinigaitis
09h05 Updates on Cough Guidelines Chair: Peter Dicpinigaitis
Highlights of the 2020 ERS Cough Management Guidelines Alyn Morice
09h25 Q&A
09h30 Pediatric updates in the CHEST cough guidelines Anne Chang
09h50 Q&A
09h55 BREAK
10h00 Issues in Cough Clinical Trials Chair: Surinder Birring
The placebo effect in cough & its relevance to antitussive clinical trials Ron Eccles
10h20 Q&A
10h25 The ideal antitussive trial design Surinder Birring
10:45 Q&A
10h50 Developing a consumer technology-based automated cough counter L. Cesnakova
11h10 Q&A
11h15 BREAK
11h30 Insights into Mechanisms of Cough Chairs: K. Fan Chung, I. Satia
CNS mechanisms regulating cough in health and disease Stuart Mazzone
11h50 Q&A
11h55 Chemosensory brush cell regulation of the cough reflex Brendan Canning
12h15 Q&A
12h20 Mechanisms of cough in asthma & non-asthmatic eosinophilic bronchitis Imran Satia
12h40 Q&A
12h45 Post-COVID-19 chronic cough: assessment 18-months into the pandemic Woo-Jung Song
13h05 Q&A
13h10 LUNCH BREAK
14h15 Issues in Clinical Cough Management Chairs: Alyn Morice, Peter Dicpinigaitis
Precision medicine approaches to diagnosis and management of RCC Jacky Smith
14h35 Q&A
14h40 The role of the Speech-Language Pathologist in the evaluation and
management of chronic cough Laurie Slovarp
15h00 Q&A
15h05 The journey of the chronic cough patient: repetitive physician visits, and
churn through the system Heikki Koskela
15h25 Q&A
15h30 Refractory Chronic Cough: What should we do now while we await the first
antitussive drug approval? K. Fan Chung
15h50 Q&A
16h00 Close of Day
PLEASE NOTE ALL TIMES ARE EDT (US Eastern)
Saturday June 12, 2021
09h00
Opening Remarks & Day 1 Recap Peter Dicpinigaitis
Update on Antitussive Clinical Trials - P2X3 antagonists Chairs: C. Page, J. Smith
09h15 Gefapixant Carmen La Rosa
09h35 Q&A
09h40 BLU-5937 Catherine Bonuccelli
10h00 Q&A
10h05 Updates on BAY 1817080 and BAY 190260 Melanie Wosnitza
10h25 Q&A
10h30 S-600918 Yuko Matsunaga
10h50 Q&A
10h55
Break
11h10
Update on Other Antitussive Clinical Trials Chair: Brendan Canning
NaV1.7 voltage-gated sodium channel blockers as antitussives
11h15 Nocion – NOC 100 (NTX-1175) Rick Batycky
11h35 Q&A
11h40 SiteOne John Hunter
12h00 Q&A
12h05 Update on NK-1-Receptor Antagonist Clinical Trials
NeRRe - Orvepitant Steve Pawsey
12h25 Q&A
12h30
Lunch Break
13h00
Oral Abstracts Chairs: Peter Dicpinigaitis, Jacky Smith
1. Guaifenesin Modifies Airway Mucus, Reduces Mucus-Cell Surface
Interactions, and Increases Mucociliary Transport in an Organotypic
In Vitro Model Phillip Clapp
2. Effects of Severity of Laryngeal Sensations on Cough-Related
Quality of Life Haruhiko Ogawa
3. A Mouse Model of Infectious Viral Cough Edward T. Wei
​
4. The Clinical Utility of Laryngoscopy in the Management of Chronic
Cough and Vocal Cord Dysfunction Anne E. Vertigan
​
5. Programmatic Desensitization of the Cough Reflex in Patients with
Refractory Chronic Cough Laurie Slovarp
​
6. Comparison of the Capsaicin-Evoked Cough Responses with Histamine-
Induced Itch and Wheal Responses in Atopic Asthma Hafsa Omer
​
7. Anxiety as a Factor in Treatment Outcomes for Chronic
Refractory Cough Miranda L. Wright
​
8. A Speech Obfuscation Algorithm for Data Privacy in 24-Hour Audio
Based Cough Monitoring Terence E. Taylor
​
9. An Artificial Intelligence Algorithm-Based Smartphone Application
Can Help To Monitor Cough In Real-Time Mandel Sher
15h00